SCENARIA View Phase vs Tempus ECG-Low EF
AI Verdict
Choose SCENARIA View Phase if…
Choose FUJIFILM SCENARIA View Phase if your healthcare facility requires a comprehensive, AI-powered CT imaging system for advanced diagnostic radiology, particularly for high-quality cardiac imaging with motion correction and low-dose lung cancer screening. This system is ideal for practices prioritizing significant radiation dose reduction, streamlined workflows, and enhanced patient comfort with its wide gantry and high table weight capacity.
View SCENARIA View Phase →Choose Tempus ECG-Low EF if…
Choose Tempus ECG-Low EF if your clinical setting needs an efficient, AI-driven software solution to quickly screen patients aged 40 or older for signs associated with low left ventricular ejection fraction using existing 12-lead ECG recordings. This tool is best suited for cardiology, emergency medicine, or internal medicine departments looking to aid in the early identification of patients at risk of heart failure to guide further diagnostic evaluation.
View Tempus ECG-Low EF →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | SCENARIA View Phase | Tempus ECG-Low EF |
|---|---|---|
| Pricing | Contact for pricing | Unknown |
| Deployment | On-premise | Integrates with current ECG platforms and electronic health records (EHRs). |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
SCENARIA View PhaseTool A, SCENARIA View Phase, offers several features that directly enhance the user experience for technicians and patient comfort during CT scans, such as AutoPose AI for automatic scan range setting, an Auto Lateral Shift Table for precise positioning, and a wide 80cm gantry. These innovations streamline the physical scanning process and improve patient interaction.
Clinical Value
Tempus ECG-Low EFTool B, Tempus ECG-Low EF, provides a highly specific and actionable clinical value by using AI to detect signs of low left ventricular ejection fraction (LVEF u226440%) from routine 12-lead ECGs. This enables early identification of patients at risk for heart failure, facilitating timely further evaluation and potential intervention for a critical condition.
Pricing & Value
TieBoth Tool A and Tool B explicitly state that their pricing is not publicly available and requires direct contact with the vendor. Without any transparent pricing information or details on their respective licensing models, it is impossible to conduct a meaningful comparison of their cost-effectiveness or overall value.
Enterprise Readiness
SCENARIA View PhaseBoth tools are FDA-cleared, HIPAA compliant, and offer BAAs, demonstrating foundational enterprise readiness. However, Tool A, as an on-premise CT system, integrates with a broader imaging ecosystem like SYNAPSE 3D and adheres to specific imaging standards such as DICOM Dose Structured Report and NEMA XR-25 compliance, indicating a more comprehensive and established integration within the enterprise imaging infrastructure.
Innovation
Tempus ECG-Low EFWhile Tool A introduces significant AI advancements in CT hardware and software for image quality and workflow, Tool B's innovation is particularly impactful in leveraging AI to extract novel, critical diagnostic information from a ubiquitous and low-cost test (ECG). This application of AI to identify a significant cardiac risk from existing data represents a highly scalable and transformative approach to early disease detection.
Support & Docs
TieNeither the provided structured facts nor the web search results offer specific, comparable details regarding support channels, service level agreements, or the comprehensiveness of documentation for either tool. While both companies are established in the healthcare sector and are expected to offer adequate support, there is no information to differentiate them on this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | SCENARIA View Phase | Tempus ECG-Low EF |
|---|---|---|
| Name | SCENARIA View Phase | Tempus ECG-Low EF |
| Company | FUJIFILM Corporation | Tempus AI |
| Description | FUJIFILM SCENARIA View Phase is an AI-powered CT system offering advanced imaging, significant dose reduction, and streamlined workflows for comprehensive diagnostic radiology, including cardiac and low-dose lung cancer screening. | Tempus ECG-Low EF is an FDA-cleared AI software that analyzes 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction (LVEF u226440%) in patients 40 years or older at risk of heart failure. It provides a binary output to aid clinicians in further evaluation. |
| Categories | Cardiology AI, Oncology AI, Radiology & Imaging AI | Cardiology AI |
| Specialties | Cardiology, Oncology, Radiology | Cardiology, Emergency Medicine, Internal Medicine |
| Key Features | AI-based iterative reconstruction (Intelli IPV) for up to 83% dose reduction and high image quality; Cardio StillShot for motion correction in cardiac CT, achieving 28ms effective temporal resolution; AutoPose AI function for automatic scan range and dimension setting based on scanogram; Wide 80cm gantry aperture and 550lbs (250kg) table weight capacity for patient comfort; Auto Lateral Shift Table (u00b110cm) for precise patient positioning and dose reduction; DICOM Dose Structured Report and Dose Check (NEMA XR-25 compliant) for dose reporting and awareness; HiMAR Plus metal artifact reduction; SYNAPSE 3D integration for advanced image analysis and automatic organ segmentation | AI-powered algorithm for ECG analysis; Detects signs of low Left Ventricular Ejection Fraction (LVEF u226440%); Analyzes resting, non-ambulatory 12-lead ECG recordings; Provides a binary output (Low LVEF Detected / Not Detected); Aids in identifying patients 40+ years at risk of heart failure; Trained on a large dataset of over 930,000 ECGs from 170,000+ patients; Intended for use in clinical diagnostic settings at healthcare facilities |
Videos
Demos, reviews, and walkthroughs featuring SCENARIA View Phase and Tempus ECG-Low EF.
Frequently Asked Questions
More Comparisons
More matchups featuring SCENARIA View Phase or Tempus ECG-Low EF
Backers
Who funded each tool's parent company.